Creso Pharma Limited
Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Hea… Read more
Market Cap & Net Worth: Creso Pharma Limited (COPHF)
Creso Pharma Limited (PINK:COPHF) has a market capitalization of $131.72 Million ($131.72 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #35025 globally and #11422 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Creso Pharma Limited's stock price $0.12 by its total outstanding shares 1125830016 (1.13 Billion).
Creso Pharma Limited Market Cap History: 2017 to 2024
Creso Pharma Limited's market capitalization history from 2017 to 2024. Data shows change from $15.54 Billion to $131.72 Million (-45.07% CAGR).
Creso Pharma Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Creso Pharma Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.31x
Creso Pharma Limited's market cap is 1.31 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $15.54 Billion | $243.80K | -$15.08 Million | 63726.75x | N/A |
| 2018 | $18.24 Billion | $578.22K | -$16.76 Million | 31542.29x | N/A |
| 2019 | $2.93 Billion | $3.63 Million | -$17.05 Million | 807.17x | N/A |
| 2020 | $3.60 Billion | $2.45 Million | -$37.58 Million | 1471.82x | N/A |
| 2021 | $1.24 Billion | $6.22 Million | -$31.77 Million | 199.16x | N/A |
| 2022 | $139.60 Million | $8.69 Million | -$32.78 Million | 16.07x | N/A |
| 2023 | $24.77 Million | $18.92 Million | -$52.45 Million | 1.31x | N/A |
Competitor Companies of COPHF by Market Capitalization
Companies near Creso Pharma Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Creso Pharma Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Creso Pharma Limited Historical Marketcap From 2017 to 2024
Between 2017 and today, Creso Pharma Limited's market cap moved from $15.54 Billion to $ 131.72 Million, with a yearly change of -45.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $131.72 Million | +431.82% |
| 2023 | $24.77 Million | -82.26% |
| 2022 | $139.60 Million | -88.73% |
| 2021 | $1.24 Billion | -65.62% |
| 2020 | $3.60 Billion | +23.08% |
| 2019 | $2.93 Billion | -83.95% |
| 2018 | $18.24 Billion | +17.39% |
| 2017 | $15.54 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2025 the market cap of Creso Pharma Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $131.72 Million USD |
| MoneyControl | $131.72 Million USD |
| MarketWatch | $131.72 Million USD |
| marketcap.company | $131.72 Million USD |
| Reuters | $131.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.